Skip to content

Day-night rhythm in human skeletal muscle metabolism

Day-night rhythm in human skeletal muscle metabolism - Day-night Rhythm in Human Skeletal Muscle

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40863
Enrollment
26
Registered
2014-08-25
Start date
2014-10-28
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

geen. n.v.t.

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Caucasian • Healthy (as determined by dependent physician based on medical questionnaire) • Male • Age: 18-35 years • Normal BMI (18-25 kg/m2) • Regular sleeping time (normally 7-9h daily)

Exclusion criteria

Exclusion criteria: • Extreme early bird or extreme night person (score =70 on MEQ-SA questionnaire) • Heavily varying sleep-wake rhythm • Shiftwork during last 3 months • Travel across >1 time zone in the last 3 months • Engagement in exercise > 2 hours total per week • Using >400mg caffeine daily (more than 4 coffee or energy drink) • Smoking • Unstable body weight (weight gain or loss > 3kg in the last 3 months) • Significant food allergies/intolerance (seriously hampering study meals) • Participation in another biomedical study within 1 month before the first study visit;• Any contra-indication to Magnetic Resonance Imaging (MRI) scanning: o Any implant or prosthesis that is contra-indicated for MRI o Metal containing foreign bodies in the eye or brain o Any other metal containing objects contra-indicated for MRI scanning o Claustrophobia o Epilepsy;• Any contra-indication to the CorTemp telemetric pill: o Known or suspected obstructive disease of the gastrointestinal tract o History of disorders or impairment of the gag reflex o Previous gastrointestinal surgery o Felinization of the esophagus o Hypomotility disorders of the gastro-intestinal tract o Implanted electromedical device;• Previous allergic reaction to Tegaderm hypoallergenic medical adhesive covering. • Any acute condition, exacerbation of chronic condition, or medical history that would in the investigator*s opinion interfere with the study

Design outcomes

Primary

MeasureTime frame
The main end-point is a day-night variation/rhythm in skeletal muscle mitochondrial function.

Secondary

MeasureTime frame
Secondary study parameters are day-night variations/rhythms in whole-body energy metabolism, skeletal muscle mRNA and protein levels and liver triglyceride concentration.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)